সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
suliqua 100/50 injizierbare lösung
sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - injizierbare lösung - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 50 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
suliqua 100/33 injizierbare lösung
sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - injizierbare lösung - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 33 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
fiasp 100 e/ml ultra-fast-acting pumpcart injektionslösung in einer patrone
novo nordisk pharma ag - insulinum aspartum - injektionslösung in einer patrone - insulinum aspartum 6.15 mg corresp. insulinum aspartum 100 u., phenolum, metacresolum, glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 6.15 mg. - diabetes mellitus - biotechnologika
জার্মানি -
জার্মান -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
insulin-injeel forte s
biologische heilmittel heel gmbh - insulinum (pot.-angaben), insulinum (pot.-angaben), insulinum (pot.-angaben), insulinum (pot.-angaben) - flüssige verdünnung zur injektion - insulinum (pot.-angaben) 0.275ml; insulinum (pot.-angaben) 0.275ml; insulinum (pot.-angaben) 0.275ml; insulinum (pot.-angaben) 0.275ml
জার্মানি -
জার্মান -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
insulin-injeel
biologische heilmittel heel gmbh - insulinum (pot.-angaben), insulinum (pot.-angaben), insulinum (pot.-angaben) - flüssige verdünnung zur injektion - insulinum (pot.-angaben) 0.367ml; insulinum (pot.-angaben) 0.367ml; insulinum (pot.-angaben) 0.367ml
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
insulin novonordisk levemir 100 e/ml penfill injektionslösung
novo nordisk pharma ag - insulinum detemirum - injektionslösung - insulinum detemirum 100 u., natrii chloridum, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 2.06 mg, phenolum 1.8 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
insulin novonordisk levemir 100 e/ml flexpen injektionslösung
novo nordisk pharma ag - insulinum detemirum - injektionslösung - insulinum detemirum 100 u., natrii chloridum, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 2.06 mg, phenolum 1.8 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
tresiba penfill injektionslösung
novo nordisk pharma ag - insulinum degludecum - injektionslösung - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
tresiba flextouch 100 e/ml injektionslösung
novo nordisk pharma ag - insulinum degludecum - injektionslösung - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
tresiba flextouch 200 e/ml injektionslösung
novo nordisk pharma ag - insulinum degludecum - injektionslösung - insulinum degludecum 1200 nmol corresp. insulinum degludecum 200 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika